SCHEMBL4307229

SCHEMBL4307229

c1ccc2c(O[Ti](Oc3cccc4ccccc34)(Oc3cccc4ccccc34)Oc3cccc4ccccc34)cccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 7/20 0.48
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
KCNA3 P22001 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 3/20 0.44
PGR P06401 1/20 0.44
GAA P10253 1/20 0.44
PTGS1 P23219 1/20 0.44
MAPK1 P28482 1/20 0.44
HTR1D P28221 1/20 0.44
CYP2A6 P11509 1/20 0.43
TSHR P16473 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SLC6A4 P31645 2/20 0.43
HRH1 P35367 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960864 0.82 HTR1B (0.46) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL8614225 0.82 HTR1B (0.46) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL4483862 0.81 SLC6A2 (0.44) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL29577853 0.77 HTR1B (0.54) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL4289478 0.77 HTR1B (0.59) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL442767 0.77 HTR1B (0.54) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL7457103 0.75 HTR1B (0.52) HTR1BALDH1A1KDM4ETDP1KCNA3
Methane SCHEMBL10959030 0.75 HTR1B (0.52) HTR1BALDH1A1KDM4ETDP1KCNA3
Lithium SCHEMBL6571336 0.75 HTR1B (0.52) HTR1BALDH1A1KDM4ETDP1KCNA3
SCHEMBL3632375 0.73 ALDH1A1 (0.52) HTR1BALDH1A1KDM4ETDP1KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034547-B1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-10-09 EP claimed
EP-3034545-A1 A process for the preparation of a graft copolymer comprising a polyolefin main chain and one or a multiple polymer side chains and the products obtained therefrom SABIC Global Technologies B.V. (NL) 2016-06-22 EP claimed
EP-3034547-A1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block and the products obtained therefrom SABIC Global Technologies B.V. (NL) 2016-06-22 EP claimed
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US claimed
US-4085250-A ORGANO TITANATE LATENT CATALYST WESTINGHOUSE ELECTRIC CORPORATION (US) 1978-04-18 US claimed
US-3998983-A Resin rich epoxide-mica flexible high voltage insulation WESTINGHOUSE ELECTRIC CORPORATION (US) 1976-12-21 US claimed
US-20260098105-A1 PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER WITH IMPROVED PROCESSABILITY AND OPTICAL PROPERTIES FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2026-04-09 US disclosed
WO-2025217072-A1 HIGH DART IMPACT AND TEAR FILMS FROM TITANIUM BASED PREPOLYMER CATALYZED POLYETHYLENES FORMOSA PLASTICS CORPORATION, USA (US) 2025-10-16 WO disclosed
US-11952445-B2 Ethylene/alpha-olefin copolymers for better optical and mechanical properties and processability of film made therefrom FORMOSA PLASTICS CORPORATION, USA (US) 2024-04-09 US disclosed
CN-111492026-B Multi-layer polyetherketoneketone articles and methods 3M创新有限公司(US) 2023-01-13 CN disclosed
US-20220153886-A1 Ethylene/Alpha-Olefin Copolymers for Better Optical and Mechanical Properties and Processability of Film Made Therefrom FORMOSA PLASTICS CORPORATION, USA 2022-05-19 US disclosed
EP-3034545-B1 A PROCESS FOR THE PREPARATION OF A GRAFT COPOLYMER COMPRISING A POLYOLEFIN MAIN CHAIN AND ONE OR A MULTIPLE POLYMER SIDE CHAINS AND THE PRODUCTS OBTAINED THEREFROM SABIC GLOBAL TECHNOLOGIES BV (NL) 2020-11-04 EP disclosed
US-10730272-B2 Heat-ray shielding film, heat-ray shielding laminated transparent substrate, automobile, building, dispersoid, mixed composition, method for manufacturing dispersoid, dispersion liquid, and method for manufacturing dispersion liquid SUMITOMO METAL MINING CO., LTD. (JP) 2020-08-04 US disclosed
EP-0578470-A2 Process for preparing polyolefins NIPPON OIL CO. LTD. (JP) 1994-01-12 EP disclosed
US-5204305-A COCATALYTIC COMPOSITION WHICH IS USABLE FOR THE POLYMERIZATION OF ALPHA-OLEFINS SOLVAY S.A. (BE) 1993-04-20 US disclosed
EP-0507574-A2 Process for preparing polyolefins NIPPON OIL COMPANY, LIMITED (JP) 1992-10-07 EP disclosed
EP-0447079-A2 Process for preparing polyolefins NIPPON OIL COMPANY, LIMITED (JP) 1991-09-18 EP disclosed
EP-0428375-A2 Process for preparing polyolefins NIPPON OIL COMPANY, LIMITED (JP) 1991-05-22 EP disclosed
US-4085250-A ORGANO TITANATE LATENT CATALYST WESTINGHOUSE ELECTRIC CORPORATION (US) 1978-04-18 US disclosed
US-3998983-A Resin rich epoxide-mica flexible high voltage insulation WESTINGHOUSE ELECTRIC CORPORATION (US) 1976-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098105-A1 PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER WITH IMPROVED PROCESSABILITY AND OPTICAL PROPERTIES DIS3, DRD4, SRP54 HTR1B 2072/4885ALDH1A1 2552/4885KDM4E 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.